is mounjaro better than semaglutide Ozempic vs Mounjaro: Comparing GLP‑1 Injectable Weight‑Loss Meds, vs Tirzepatide, and Real Side Effects Wegovy vs Mounjaro | Semaglutide

GLP-1 receptors are widely distributed throughout the body, including the pancreas, brain, and gastrointestinal tract

(Diabetes, Obesity and Metabolism, 2025) showed that tirzepatide reduced total lean mass by 10.9% over 72 weeks

Important safety considerations include a boxed warning for thyroid C-cell tumors (contraindicated in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2), risk of pancreatitis, gallbladder disease, and diabetic retinopathy complications

Abstract Aims/hypothesis Anti-CD3 monoclonal antibody (aCD3) delays progression to stage 3 type 1 diabetes in high-risk individuals by modulating autoimmune activity